| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAGULATION FACTOR VIIA RECOMBINANT HUMAN | 1 | 0.0108 |
| 1 | COAGULATION FACTOR VIIA (RECOMBINANT) | 7 | 0.0026 |
| 2 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 3 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL | 1 | 0.0006 |
| 4 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 2 | 0.0002 |
| 5 | IDELALISIB | 1 | 0.0001 |
| 6 | DARUNAVIR | 1 | 0.0001 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0000 |
| 8 | RITUXIMAB | 2 | 0.0000 |
| 9 | RAMIPRIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 7 | Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 | 0.0000 |